According to a recent market analysis by Future Market Insights (FMI), the demand for Protein A Resins is expected to grow at an 8.1% CAGR, surpassing US$ 1.2 Bn by 2031.
The demand for protein A resins will be driven by research on monoclonal antibodies and the development of biosimilar drugs. The global need for advanced and precise biosimilars to reduce cancer risk is spurring research on monoclonal antibodies.
Download a Sample Copy of report to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
According to FMI, the demand for protein A resins in contract manufacturing organisations is increasing (CMO). Favorable research initiatives and funding in CMOs for the production of monoclonal antibodies will drive market growth.
The COVID-19 outbreak accelerated the sale of protein A resins as the development of monoclonal antibodies for virus treatment increased. Aside from that, during the FQ-20, there was a surge in demand for natural protein A resins used in the purification of monoclonal antibodies.
Natural protein A resins are being increasingly used in advanced research because they reduce ligand leaching and provide stability to traditional protein A resins. As a result, demand for natural protein A resins in biopharmaceutical manufacturing companies is expected to rise over the forecast period.
According to FMI, sales of protein A resins for antibody purification will account for the majority of the market during the forecast period. The increasing prevalence of cancer and other chronic diseases has increased the demand for monoclonal antibodies for therapeutic purposes.
As a result, biopharmaceutical manufacturers are actively seeking strategic alliances and mergers with other key players in order to launch new products, therapeutic drugs, and gain a competitive advantage in the industry.
“Steered by increasing demand for biosimilar and monoclonal antibodies for therapeutic use, biopharmaceutical manufacturing companies are increasing investments in research and development activities to push biologics production. This is expected to create lucrative growth opportunities for market players,” says an FMI analyst.
Ask from the Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-1720
Key Takeaways:
- The U.S. is expected to dominate the North America’s protein A resins market, holding over 93.5% market share
- The U.K. will account for nearly 24.1% of market share across Europe due to increasing number of biopharmaceutical companies focusing on development of biosimilar drugs
- China is expected to register growth at 9.8% CAGR in East Asia owing to the increasing use of biomaterials in drug research
- Sales of protein A resins across Japan are expected to increase at 7.8% CAGR during the forecast period
- Based on matrix type, agarose based matrix of protein A resins will account for over 85.8% market share in 2021
- Biopharmaceutical manufacturers are expected to be the primary end-users, accounting for 79.2% market share in 2021
Prominent Drivers:
- Growing demand for therapeutic antibodies and extensive research on monoclonal antibodies will boost the market
- Increasing prevalence of cancer has encouraged medical professionals for extensive research on the production of monoclonal antibodies for therapeutic use. This is propelling the demand in the market
Key Restraints:
- High cost of resins and lack of skilled research analysts are expected to restrict the growth in protein A resins market
Competitive Landscape
Key players are collaborating with end users and other regional players to strengthen their global presence. Some of the market players are focusing on product launches to capitalize on growing demand for monoclonal antibodies from biopharmaceutical companies. For instance:
- In Spetember 2021, Purolite, a global manufacturer of resin-based chromatography separation, purification, and extraction technologies, announced the commercialization of two novel next-generation chromatography resins.
- In March 2020, Avantor Inc., global provider of mission-critical products and services to customers in the life-sciences, announced a new recombinant Protein A affinity chromatography resin, PROchievA, used to purify antibodies during mAbs production.
Request for Customized Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-1720
Leading players operating in protein A resins market profiled by FMI include:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
- Others
More Insights on FMI’s Protein A Resins Market
The latest market study on the protein A resins market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to offer a better perspective of the global protein A resins market, its growth trajectory, trends, and opportunities, the market is segmented on the basis of:
By Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
By Matrix:
- Agarose Based Matrix
- Glass or Silica Based Matrix
- Organic Polymer Based Matrix
By Application:
- Immunoprecipitation
- Antibody Purification
By End-User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
